Session

Challenges in minimally invasive partial nephrectomy

Poster Session 79

  • Location:
    Room Copenhagen, North Hall (Level 1)
  • Chairs:
     M. Gallucci, Rome (IT)
     G. Novara, Padova (IT)
  • Aims and objectives of this session

    Exchange of experiences with challenging minimally invasive partial nephrectomies.

  • Poster viewing of 20 minutes. Presentations will take place on stage. Standard presentations are 2 minutes in length, followed by 2 minutes for discussion.
1051
Perioperative outcomes between open and robot-assisted partial nephrectomy for cystic masses: An international multicentric study

By: Pradere B.1, Peyronnet B.2, Delporte G.3, Manach Q.4, Khene Z.2, Riszk J.3, Moulin M.7, Benoit T.5, Brichart N.6, Beauval J.B.5, Bex A.8, Roupret M.4, Bensalah K.2, Bruyère F.9

Institutes: 1CHRU de Tours, Hôpital Bretonneau, Dept. of Urology, Tours, France, 2CHU Rennes, Dept. of Urology, Rennes, France, 3CHRU Lille, Dept. of Urology, Lille, France, 4Hopital Pitié-Salpêtrière, Dept. of Urology, Paris, France, 5CHU Toulouse, Dept. of Urology, Toulouse, France, 6CHR Orléans, Dept. of Urology, Orléans, France, 7CHU Dijon, Dept. of Urology, Dijon, France, 8Netherlands Cancer Institute, Dept. of Urology, Amsterdam, The Netherlands, 9CHRU Tours, Dept. of Urology, Tours, France

1044
MIC and Trifecta in robot-assisted partial nephrectomy in highly complex tumors – similar results in comparison with tumors of low and intermediate complexity

By: Harke N.N.1, Wagner C.2, Schiefelbein F.3, Trabs G.3, Roosen A.4, Ubrig B.4, Schoen G.3, Witt J.2

Institutes: 1University of Rostock, Dept. of Urology, Rostock, Germany, 2St. Antonius Hospital, Prostate Center Northwest, Dept. of Urology, Pediatric Urology and Urologic Oncology, Gronau, Germany, 3Missionsaerztliche Klinik, Dept. of Urology, Wuerzburg, Germany, 4Augusta-Kranken-Anstalt, Dept. of Urology, Bochum, Germany

1046
Histopathological analysis of peritumoral pseudocapsule infiltration and surgical margin status after enucleative robot-assisted partial nephrectomy (RAPN) for malignant renal tumors

By: Campi R.1, Mari A.1, Sessa F.1, Tellini R.1, Rudi X.1, Sforza S.1, Vanacore D.1, Tuccio A.1, Serni S.1, Carini M.1, Raspollini M.R.2, Minervini A.1

Institutes: 1Aou Careggi, Dept. of Urology, Florence, Italy, 2Aou Careggi, Dept. of Pathology, Florence, Italy

1047
Adherent perinephric fat in Asian patients: Predictors, and impact on perioperative outcomes of partial nephrectomy

By: Kawamura N., Saito K., Inoue M., Ito M., Kijima T., Yoshida S., Yokoyama M., Ishioka J., Matsuoka Y., Kihara K., Fujii Y.

Institutes: Tokyo Medical and Dental University Graduate School, Dept. of Urology, Tokyo, Japan

1048
Robotic-assisted partial nephrectomy for hilar and non-hilar tumours: Perioperative outcomes

By: Lu S-Y., Chung H-J., Huang Y-H., Lin T-P., Lin A., Chen K-K.

Institutes: Taipei Veterans General Hospital, Dept. of Urology, Taipei City, Taiwan

1049
Is retro the way forward? Retroperitoneal robotic-assisted partial nephrectomy: Single institution experience

By: Hussain M., Oakley J., Muller G., Emara A., Barber N.

Institutes: Frimley Park Hospital, Dept. of Urology, Surrey, United Kingdom

1050
Comparison of laparoscopic and robotic partial nephrectomy beyond the learning curve

By: Alimi Q.1, Peyronnet B.1, Sebe P.2, Coté J-F.3, Kammerer-Jacquet S-F.4, Khene Z.1, Verhoest G.1, Guillonneau B.5, Bensalah K.1

Institutes: 1CHU Pontchaillou Teaching Hospital, Dept. of Urology, Rennes, France, 2Diaconesses Croix St Simon Hospital, Dept. of Urology, Paris, France, 3CHU Tenon Teaching Hospital, Dept. of Pathology, Paris, France, 4CHU Pontchaillou Teaching Hospital, Dept. of Pathology, Rennes, France, 5Diaconesses Croix Saint Simon Hospital, Dept. of Urology, Paris, France

1052
Robot-assisted partial nephrectomy for complex cases (Padua score ≥ 10): Results from a multicenter experience at three high-volume centers

By: Lughezzani G.1, Buffi N.1, Lista G.1, Maffei D.1, Forni G.1, Larcher A.2, Fossati N.2, Lazzeri M.1, Casale P.1, Saita A.1, Hurle R.1, Guazzoni G.1, Porter J.3, Mottrie A.2

Institutes: 1Istituto Clinico Humanitas, IRCCS, Dept. of Urology, Milan, Italy, 2OLV Vattikuti Robotic Center, Dept. of Urology, Aalst, Belgium, 3Swedish Medical Center, Dept. of Urology, Seattle, United States of America

1053
3D versus 2D laparoscopic partial nephrectomy: Feasibility and advantages

By: Varca V., Benelli A., Gregori A.

Institutes: G. Salvini Hospital, Dept. of Urology, Milan, Italy

1054
Intraoperative dual-modality imaging in clear cell renal cell carcinoma using Indium-111-DOTA-girentuximab-IRDye800CW

By: Hekman M.1, Rijpkema M.2, Oosterwijk E.3, Langenhuijsen H.3, Boerman O.2, Oyen W.2, Mulders P.3

Institutes: 1Radboudumc, Dept. of Urology and Dept. of Radiology & Nuclear Medicine, Nijmegen, The Netherlands, 2Radboudumc, Dept. of Radiology & Nuclear Medicine, Nijmegen, The Netherlands, 3Radboudumc, Dept. of Urology, Nijmegen, The Netherlands

1055
Partial nephrectomy in the treatment of renal tumors with concomitant venous tumor thrombosis (VTT) of renal vein branches: Retrospective, multi-center analysis of perioperative, functional, and oncologic outcomes

By: Zattoni F.1, Thompson R.2, Capitano U.3, Crestani A.4, Ficarra V.4, Kutikov A.5, Larcher A.3, Lane B.6, Leibovich B.7, McIntosh A.8, Montorsi F.3, Moon D.9, Muilwijk T.10, Murray K.11, Noyes S.6, Russo P.12, Uzzo R.8, Van Poppel H.10, Yang D.7, Zattoni F.13, Mottrie A.14, Novara G.13

Institutes: 1University of Padua and University of Udine, Dept. of Surgery, Oncology, and Gastroenterology – Urology Clinic, University of Padua – Department of Experimental and Clinical Medical Sciences – Urologic Clinic, University of Udine, Padua and Udine, Italy, 2Mayo Clinic, Dept. of Urology, Rochester, Mn, United States of America, 3URI, IRCCS Ospedale San Raffaele, Division of Oncology, Unit of Urology, Milan, Italy, 4University of Udine, Italy, Dept. of Experimental and Clinical Medical Sciences – Urologic Clinic, Udine, Italy, 5Fox Chase Cancer Center, Temple University Health System, Division of Urologic Oncology, Department of Surgical Oncology, Philadelphia, Pa, United States of America, 6College of Human Medicine, Michigan State University, Division of Urology, Spectrum Health, Grand Rapids, United States of America, 7Mayo Clinic, Dept. of Urology, Rochester, United States of America, 8Fox Chase Cancer Center, Temple University Health System, Division of Urologic Oncology, Department of Surgical Oncology, Philadelphia, United States of America, 9Peter MacCallum Cancer Centre, Epworth Healthcare, University of Melbourne, Division of Cancer Surgery, Melbourne, Australia, 10University Hospitals,Leuven, Dept. of Urology and Radiation Oncology, Leuven, Belgium, 11University of Missouri, Dept. of Surgery-Urology Division, Columbia, United States of America, 12Memorial Sloan Kettering Cancer Center, Urology Service, New York, United States of America, 13University of Padua, Dept. of Surgery, Oncology, and Gastroenterology – Urology Clinic,university of Padua – Department of Experimental and Clinical Medical Sciences – Urologic Clinic, University of Udine, Padua, Italy, 14Onze Lieve Vrouwziekenhuis Hospital, Dept. of Urology, Aalst, Belgium

1056
Simple enucleation for selected renal tumours ≥7 cm

By: Lu Q.1, Zhao X.1, Ji C.1, Guo S.2, Liu G.1, Zhang S.1, Li X.1, Gan W.1, Guo H.1

Institutes: 1Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Dept. of Urology, Nanjing, China, 2Nanjing Medical University, School of Public Health, Nanjing, China

Summary
 M. Gallucci, Rome (IT)